Cytotoxicity mediation of cells evidencing surface expression of CD44

Details for Australian Patent Application No. 2005226797 (hide)

Owner F.Hoffmann-La Roche AG

Inventors Findlay, Helen P.; Young, David S. F.; Hahn, Susan E.

Agent Davies Collison Cave

Pub. Number AU-B-2005226797

PCT Pub. Number WO2005/092375

Priority 10/810,165 26.03.04 US

Filing date 23 March 2005

Wipo publication date 6 October 2005

Acceptance publication date 18 August 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/00 (2006.01) Preparations for testing

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 33/567 (2006.01) Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

19 October 2006 PCT application entered the National Phase

  PCT publication WO2005/092375 Priority application(s): WO2005/092375

21 May 2009 Assignment before Grant

  Arius Research, Inc. The application has been assigned to F.Hoffmann-La Roche AG

18 August 2011 Application Accepted

  Published as AU-B-2005226797

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005226798-Cytotoxicity mediation of cells evidencing surface expression of MCSP

2005226795-Spinal and upper cervical impulse treatment device